Jazz Pharmaceuticals Equity Award Letter to Samantha Pearce (December 2019)

Summary

Jazz Pharmaceuticals UK Limited is offering Samantha Pearce an equity award as part of her employment. She will receive 25,500 stock options and 10,200 restricted stock units (RSUs) from Jazz Pharmaceuticals plc, subject to company approval and the terms of the 2011 Equity Incentive Plan. The stock options' exercise price will match the closing price on the grant date, while RSUs will convert to shares upon vesting. The award is contingent on the company's policies and the terms outlined in the award agreement.

EX-10.28B 7 jazzq42019ex1028b.htm EQUITY AWARD LETTER Exhibit

Exhibit 10.28B

[Jazz Pharmaceuticals Letterhead]

CONFIDENTIAL

Samantha Pearce

[Address]

9 December 2019

Re: New Hire Equity Award

Dear Samantha,

Welcome to Jazz Pharmaceuticals. In connection with your employment by Jazz Pharmaceuticals UK Limited, you will also receive an equity award from Jazz Pharmaceuticals plc in the amounts shown below, subject to approval in accordance with the policies and guidelines of Jazz Pharmaceuticals plc.

Award of Stock Options: 25,500

Award of Restricted Stock Units (RSUs): 10,200

Your stock options will have an exercise price equal to the closing price of Jazz Pharmaceuticals plc ordinary shares on NASDAQ on the grant date, and will be made pursuant to the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan and subject to the other terms contained in your award agreement.

Your RSUs will represent your right to receive Jazz Pharmaceuticals plc ordinary shares upon vesting and settlement, according to the vesting schedule in your grant notice, and will be made pursuant to the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan and subject to the other terms contained in your award agreement. RSUs have no exercise price.

If you have questions, please feel free to discuss them with Stock Administration.

/s/ SP

Please initial to acknowledge receipt of this letter